Adam G. Sternberg

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group

K. Matthay, P. Adamson, R. Seeger, 2006, Clinical Cancer Research.